Verastem | VSTM - صافي الدخل





صافي الدخل تغيير تاريخ
AbbVie USD 1.82B 1.63B 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
AstraZeneca USD 2.33B 207M 2025-12
Curis USD 19.36M 31.16M 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12
Verastem USD -32.92M 24.66M 2025-12